Related Experiment Video
Updated: Aug 1, 2026
13:02
Generating iPS Cells from MEFS through Forced Expression of Sox-2, Oct-4, c-Myc, and Klf4
Published on: April 7, 2008
36.8K
MDM4 enables efficient human iPS cell generation from PBMCs using synthetic RNAs.
Masato Nakagawa1,2, Mizuho Nogi3, Hatsuki Doi3
1Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp.
Scientific Reports
|September 8, 2025
Summary
Generating induced pluripotent stem cells (iPS cells) from peripheral blood mononuclear cells (PBMCs) is now possible using synthetic RNA. The study found that suppressing p53 with MDM4 enhances iPS cell reprogramming efficiency from PBMCs.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
- Molecular Biology
Background:
- Induced pluripotent stem cells (iPS cells) hold promise for regenerative and personalized medicine.
- Current methods for iPS cell generation from blood cells are limited, with no established protocols for peripheral blood mononuclear cells (PBMCs).
Purpose of the Study:
- To establish an efficient method for generating iPS cells from PBMCs using synthetic RNA.
- To investigate factors that improve the efficiency of iPS cell reprogramming from PBMCs.
Main Methods:
- Generation of iPS cells from PBMCs using synthetic RNA.
- Evaluation of reprogramming efficiency.
- Investigation of the role of MDM4 in p53 suppression and its effect on reprogramming.
Main Results:
- Successfully established a method to generate iPS cells from PBMCs using synthetic RNA.
- Identified MDM4 as a factor that improves reprogramming efficiency by suppressing p53.
- Demonstrated the potential for iPS cell derivation from a readily accessible blood source.
Conclusions:
- A novel method for iPS cell generation from PBMCs using synthetic RNA has been developed.
- MDM4 plays a crucial role in enhancing iPS cell reprogramming efficiency.
- This advancement facilitates the application of iPS cells in regenerative and personalized medicine.
